Navigation Links
Medarex Announces Initiation of Phase 2 Clinical Trials for the Treatment of Ulcerative Colitis and Rheumatoid Arthritis
Date:5/12/2008

rd-looking statements, as defined by the Private Securities Litigation Reform Act of 1995, that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results, performance or achievements expressed or implied by such statements. Statements that are not historical facts, including statements preceded by, followed by, or that include the words "preliminary"; "potential"; "may"; or similar statements are forward-looking statements. Medarex disclaims, however, any intent or obligation to update these forward-looking statements. Risks and uncertainties include risks associated with the development of MDX-1100, unforeseen safety issues resulting from the administration of antibody products in humans, as well as risks detailed from time to time in Medarex's public disclosure filings with the U.S. Securities and Exchange Commission (SEC), including its Annual Report on Form 10-K for the fiscal year ended December 31, 2007 and its quarterly reports on Form 10-Q. There can be no assurance that such product development efforts will succeed, or whether other developed products will receive required regulatory clearance or that, even if such regulatory clearance were received, such products would ultimately achieve commercial success. Copies of Medarex's public disclosure filings are available from its investor relations department.

Medarex(R), the Medarex logo and UltiMAb(R) are registered trademarks of Medarex, Inc. All rights are reserved.


'/>"/>
SOURCE Medarex, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Medarex Announces Allowance of Investigational New Drug Applications for Wholly Owned Fully Human Anti-CD19 Antibody, MDX-1342
2. Medarex to Receive Milestone Payment from Amgen
3. Medarex Announces Ipilimumab Program Continues to Move Forward
4. Medarex Reports Interim Data from Ongoing Ipilimumab Combination Phase 1 Studies in Prostate Cancer at American Association for Cancer Research Meeting
5. Medarex Announces Presentations at Annual Meeting of the American Society of Clinical Oncology
6. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
7. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
8. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
9. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
10. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
11. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... SHANGHAI , Sept. 22, 2014 ... global knowledge leader in healthcare technology, media and ... healthcare innovation in China ... technologies. Continua and BHG announced this new partnership ... this week in Washington, DC ...
(Date:9/22/2014)... -- Research and Markets has announced ... (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave) Market - ... On the basis of type ... been divided into eight major segments, namely, light/laser, ... ablation technologies. The light/laser ablation technology segment accounted ...
(Date:9/22/2014)... , Sept. 22, 2014  Olympus, a global ... for medical and surgical procedures, among other core ... with Munich -based Brainlab to ... Navigation. This agreement applies to the US ... U.S. sales and all distribution outside the U.S. ...
Breaking Medicine Technology:Continua and Borderless Healthcare Group Form Strategic Partnership, Launch the Healthcare Technology Innovation Center in Shanghai 2Continua and Borderless Healthcare Group Form Strategic Partnership, Launch the Healthcare Technology Innovation Center in Shanghai 3Continua and Borderless Healthcare Group Form Strategic Partnership, Launch the Healthcare Technology Innovation Center in Shanghai 4Global Ablation Technologies (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave) Market - Forecasts to 2019 2Global Ablation Technologies (Radiofrequency, Ultrasound, Irreversible Electroporation, Cryotherapy, Microwave) Market - Forecasts to 2019 3Olympus Partners with Brainlab as Exclusive Distributor for ENT Products in U.S. Market 2Olympus Partners with Brainlab as Exclusive Distributor for ENT Products in U.S. Market 3Olympus Partners with Brainlab as Exclusive Distributor for ENT Products in U.S. Market 4
... June 22, 2011 Life Technologies Corporation ... that the company has led a successful consortium ... the Oxford NIHR Biomedical Research Centre, AstraZeneca, and ... Johnson & Johnson Pharmaceutical Research & Development, L.L.C. ...
... June 22, 2011 Reportlinker.com announces that ... in its catalogue: U.S. ... http://www.reportlinker.com/p0559270/US-Urinary-Incontinence-Devices.html?utm_source=prnewswire&utm_medium=pr&utm_campaign=Food_Ingredient This research ... incontinence device market. The urinary incontinence device ...
Cached Medicine Technology:Life Technologies Consortium to Create New Frontline Diagnostic Utilising DNA Sequencing for Cancer Patients in the U.K. 2Life Technologies Consortium to Create New Frontline Diagnostic Utilising DNA Sequencing for Cancer Patients in the U.K. 3Life Technologies Consortium to Create New Frontline Diagnostic Utilising DNA Sequencing for Cancer Patients in the U.K. 4Life Technologies Consortium to Create New Frontline Diagnostic Utilising DNA Sequencing for Cancer Patients in the U.K. 5Life Technologies Consortium to Create New Frontline Diagnostic Utilising DNA Sequencing for Cancer Patients in the U.K. 6Life Technologies Consortium to Create New Frontline Diagnostic Utilising DNA Sequencing for Cancer Patients in the U.K. 7Reportlinker Adds U.S. Urinary Incontinence Devices 2Reportlinker Adds U.S. Urinary Incontinence Devices 3Reportlinker Adds U.S. Urinary Incontinence Devices 4
(Date:9/22/2014)... September 19, 2014 -- Recent two-generation approaches to ... are receiving increasing attention from researchers, advocates, and ... to enable them to move to jobs that ... early care and education for children, these programs ... However, according to a new report from ...
(Date:9/22/2014)... RESTON, Va. (PRWEB) September 22, 2014 ... (WEDI), the nation’s leading nonprofit authority on ... in healthcare information exchange, announced findings from its ... unique Health Plan Identifier (HPID) within electronic transactions ... Act (HIPAA). WEDI conducted the survey from August ...
(Date:9/22/2014)... HealthDay Reporter MONDAY, Sept. 22, ... What can I do to help ensure a healthy baby? ... may play a role in reducing the risk of having ... found that mothers of children with autism were significantly less ... than those whose children seem to be developing normally. ...
(Date:9/22/2014)... 2014 Severe weather can occur with little warning, ... as part of National Preparedness Month, Amica Insurance is ... for the unexpected:, , Build an emergency supply ... and one gallon of water per person per day for at ... plan that includes pets so your family knows what to do ...
(Date:9/22/2014)... The struggles that lie in communication between ... been well-documented—reportedly, language barriers between doctors and patients are ... room and an increased likelihood for fatal consequences and ... the largest medical facility in the Fargo, ND and ... the need for Video Remote Interpreting (VRI), ...
Breaking Medicine News(10 mins):Health News:A two-generation lens: Current state policies fail to support families with young children 2Health News:WEDI Announces Survey Results from Unique Health Plan Identifier (HPID) Industry Poll 2Health News:WEDI Announces Survey Results from Unique Health Plan Identifier (HPID) Industry Poll 3Health News:Could Low Iron Intake During Pregnancy Raise Autism Risk? 2Health News:Could Low Iron Intake During Pregnancy Raise Autism Risk? 3Health News:Amica Shares Tips for National Preparedness Month 2Health News:Healthcare Cost Savings Case Study:Stratus Video Interpreting Assists Sanford Health System in Accommodating Increasing LEP Population,Saves a Predicted $100,000 Per Year 2Health News:Healthcare Cost Savings Case Study:Stratus Video Interpreting Assists Sanford Health System in Accommodating Increasing LEP Population,Saves a Predicted $100,000 Per Year 3Health News:Healthcare Cost Savings Case Study:Stratus Video Interpreting Assists Sanford Health System in Accommodating Increasing LEP Population,Saves a Predicted $100,000 Per Year 4
... LONDON: Children who attend day care or play groups ... most common type of childhood leukaemia than those who ... investigating the link. , The new research, to ... Causes and Prevention of Childhood Leukaemia Conference in London, ...
... Retire from Company -, LAVAL, QC, April ... today announced that Claire Brulle, M.D. has been ... Company. Incumbent,Chief Medical Officer Dr. Sylvie Bouchard has ... practicing medicine., "Dr. Brulle brings to Labopharm ...
... Authentidate,Holding Corp. (Nasdaq: ADAT ), ... and web-based services, today announced that United,Seating ... providers of comprehensive,seating and mobility solutions for ... platform from Authentidate(R) to facilitate its,mobility provisioning ...
... TRIANGLE PARK, N.C., April 28 Tryton Medical,Inc. ... Davis as President and,Chief Executive Officer. Founded in ... that are designed to definitively treat bifurcation,lesions., ... 20-year career with,Guidant and Eli Lilly & Company. ...
... (Oakland, Calif.) Diabetes before motherhood more than doubled ... to a Kaiser Permanente study published in the May ... previous studies have looked exclusively at gestational diabetes (diabetes ... baby is born), this is the largest and most ...
... the Universities of Exeter and Coventry have developed the ... the rapid diagnostic tests (RDTs) currently used in the ... suggest that the technique could be as effective as ... potentially viable alternative. The team is now working on ...
Cached Medicine News:Health News:New analysis finds daycare attendance early in life cuts childhood leukemia risk by 30 percent 2Health News:New analysis finds daycare attendance early in life cuts childhood leukemia risk by 30 percent 3Health News:Labopharm Appoints Dr. Claire Brulle as Senior Vice-President and Chief Medical Officer 2Health News:Leading Provider United Seating & Mobility Implements Authentidate's Inscrybe Healthcare Platform to Standardize and Streamline Administrative Processes 2Health News:Leading Provider United Seating & Mobility Implements Authentidate's Inscrybe Healthcare Platform to Standardize and Streamline Administrative Processes 3Health News:Leading Provider United Seating & Mobility Implements Authentidate's Inscrybe Healthcare Platform to Standardize and Streamline Administrative Processes 4Health News:J. Greg Davis Appointed President & Chief Executive Officer of Tryton Medical, Inc. 2Health News:Kaiser Permanente study finds diabetes doubling before motherhood 2Health News:Kaiser Permanente study finds diabetes doubling before motherhood 3Health News:Exeter engineers create new technique for malaria diagnosis 2